论文部分内容阅读
腺样囊性癌(adenoid cystic carcinoma,ACC)具有侵袭性强、血行转移率高、预后差、易复发等特点。目前尚缺乏有效客观的生化指标对ACC的病情判断、治疗方式的选择及预后进行判断。本研究旨在探讨核因子КB(nuclear factor kappa B,NF-КB)和B淋巴细胞瘤-2基因(B-cell lymphoma-2,Bcl-2)在ACC的表达,为ACC蛋白水平的治疗提供一个新思路,报告如下。材料与方法1.材料(1)标本来源:本组60例涎腺组织标本,取
Adenoid cystic carcinoma (ACC) has strong invasiveness, high hematogenous metastasis, poor prognosis and easy recurrence. There is still a lack of effective and objective biochemical indicators to judge the condition of ACC, the choice of treatment and prognosis. This study aimed to investigate the expression of nuclear factor kappa B (NF-КB) and B-cell lymphoma-2 (Bcl-2) in ACC, A new idea, the report is as follows. Materials and methods 1. Materials (1) specimen source: The group of 60 cases of salivary gland tissue samples taken